Multinational firms calls for review of massive drug price cut plan

The Korean Research based Pharmaceutical Industry Association (KRPIA) announced Tuesday that the government’s plan to cut drug prices by an average of 14 percent starting next year should be reviewed again among related interest parties, claiming that the measure will affect the development of the Korean pharmaceutical industry.

So far, the KRPIA has argued that the plan should be implemente...